A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report
Open Access
- 8 June 2012
- journal article
- case report
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 12 (1) , 39
Abstract
Background: Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of a lysosomal hydrolase, the enzyme α-galactosidase A (GLA). This inactivation is responsible for the storage of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. The incidence of disease is estimated at 1:40,000 in the general population, although neonatal screening initiatives have found an unexpectedly high prevalence of genetic alterations, up to 1:3,100, in newborns in Italy, and have identified a surprisingly high frequency of newborn males with genetic alterations (about 1:1,500) in Taiwan. Case presentation: We describe the case of a 40-year-old female patient who presented with transient ischemic attack (TIA), discomfort in her hands, intolerance to cold and heat, severe angina and palpitations, chronic kidney disease. Clinical, biochemical and molecular studies were performed. Conclusions: Reported symptoms, peculiar findings in a renal biopsy – the evidence of occasional lamellar inclusions in podocytes and mesangial cells – and left ventricular (LV) hypertrophy, which are considered to be specific features of FD, as well as molecular evaluations, suggested the diagnosis of a classical form of FD. We detected four mutations in the GLA gene of the patient: -10C>T (g.1170C>T), c.370-77_-81del (g.7188-7192del5), c.640-16A>G (g.10115A>G), c.1000-22C>T (g.10956C>T). These mutations, located in promoter and intronic regulatory regions, have been observed in several patients with manifestations of FD. In our patient clinical picture showed a multisystemic involvement with early onset of symptoms, thus suggesting that these intronic mutations can be found even in patients with classical form of FD.Keywords
This publication has 20 references indexed in Scilit:
- Genetic screening of Fabry patients with EcoTILLING and HRM technologyBMC Research Notes, 2011
- Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot studyEuropean Journal of Neurology, 2010
- Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A)Human Mutation, 2009
- Alternative splicing and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- MRI Characterization of Myocardial Tissue in Patients with Fabry's DiseaseAmerican Journal of Roentgenology, 2007
- Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype1Kidney International, 2003
- Alternative Splicing in the α-Galactosidase A Gene: Increased Exon Inclusion Results in the Fabry Cardiac PhenotypeThe American Journal of Human Genetics, 2002
- Fabry disease: enzymatic diagnosis in dried blood spots on filter paperClinica Chimica Acta, 2001
- An Atypical Variant of Fabry's Disease in Men with Left Ventricular HypertrophyNew England Journal of Medicine, 1995
- Sequence variations in the first exon of alpha-galactosidase A.Journal of Medical Genetics, 1993